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Abstract Adhesion is the first step in the patho-
genesis of enterotoxigenic Escherichia coli
infections. The genes encoding the most prevalent
adhesion factors CFA/I, CS3 and CS6 were cloned
into Vibrio cholerae strain CVD 103–HgR and
expression of fimbriae was investigated in wildtype
and recombinant strains by transmission electron
microscopy in conjunction with immunolabelling and
negative staining. Negative staining was effective in
revealing CFA/I and CS3, but not CS6. Although
morphology of fimbriae differed between wildtype
and recombinant strains, corresponding surface anti-
gens were recognized by specific antibodies. The
present study provides evidence that ETEC-specific
fimbriae can adequately be expressed in an attenuated
V. cholerae vaccine strain and that immunoelectron
microscopy is a critical tool to validate the surface
expression of antigens in view of their possible
suitability for recombinant vaccines.
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Introduction
Infection with enterotoxigenic Escherichia coli
(ETEC) is one of the major causes of diarrhea
affecting travelers and residents in endemic countries
(Jiang et al. 2002; Oyofo et al. 2001). A number of
antibiotic drugs are able to prevent diarrhea for a
limited period of time, but the potential for adverse
effects and the risk of selecting resistant pathogens
calls for a restrictive use of antibiotics and for other
prophylactic measures. Therefore an enormous effort
has been initiated worldwide to develop a safe and
effective vaccine against ETEC.
Infections with ETEC require proper adhesion of
bacteria to the intestinal mucosa. This first step in the
pathogenesis of ETEC diarrhea is mediated through
specific surface structures called pili or fimbriae
(Jonson et al. 2005), which allow the bacteria to
colonize the mucosal surface of the small intestine.
Termed Colonization Factors (CF), these proteins are
subdivided into colonization factor antigens (CFA),
which include CFA/I, CFA/II, CFA/III and CFA/IV,
and a number of so-called coli surface antigens (CS).
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CFA/I and CFA/III are rodlike fimbrial antigens with
diameters of 6–8 nm (Knutton et al. 1985; Levine
et al. 1984). CFA/II itself consists of three distinct
coli surface (CS) antigens, CS1, CS2 and CS3.
Whereas CS1 and CS2 are morphologically similar to
CFA/I, CS3 was shown to consist of fine fibrils with a
diameter of 2–3 nm (Levine et al. 1984) CFA/IV
comprises three distinct coli surface antigens, CS4,
CS5 and CS6. CS4 and CS5 are rodlike fimbriae,
whereas the morphology of CS6 has not yet been
elucidated (de Lorimier et al. 2003; Knutton et al.
1989; Nishikawa et al. 1998).
In order to assess the potential of V. cholerae as a
carrier, the genes encoding the most common ETEC
surface antigens, CFA/I, CS3 and CS6, were cloned
into the vaccine strain CVD 103-HgR (Ketley et al.
1993) alone or in combination. Using transmission
electron microscopy (TEM) in conjunction with
negative staining and immunolabelling, recombinant
CVD strains were then compared to ETEC wildtype
strains. The present study provides evidence that
specific surface antigens can be expressed at the
surface of the V. cholerae CVD 103-HgR and that
resulting recombinant strains may be expected to
elicit a proper antibody response.
Materials and methods
Bacterial strains, culture conditions and
preparation of whole mounts for transmission
electron microscopy (TEM)
ETEC wildtype and recombinant V. cholerae strains
expressing the respective surface antigens as well as
the plasmids used have been reported previously
(Favre et al. 2006). Stability of plasmids in recombi-
nant strains was analyzed by growing the cultures in
exponential phase for ten generations without selec-
tive pressure of antibiotics. Persistence of plasmids
was then confirmed in single colony isolates by
growth on solid medium containing the correspond-
ing antibiotics and by plasmid purification.
Bacteria were grown on solid CF-medium (Evans
et al. 1979) overnight at 37C. Antibiotics were
included as appropriate (34 lg/ml of Chlorampheni-
col, 50 lg/ml of Kanamycin and 50 lg/ml of
Ampicillin, either alone or in combination). Thereaf-
ter, bacteria were rinsed off the culture plates with
0.85% NaCl pre-warmed to 37C and the bacterial
suspension was fixed immediately by adding an equal
volume of paraformaldehyde fixative (final concentra-
tion: 0.1% paraformaldehyde in 0.01 M phosphate-
buffered saline, pH 7.4) or of diluted Karnovsky’s
fixative (final concentration: 2.5% glutaraldehyde, 2%
paraformaldehyde in 0.1 M cacodylate buffer, pH 7.4),
respectively. Bacteria were then adsorbed onto parlo-
dion-coated copper or nickel grids by placing a grid
upside down onto a drop of bacterial suspension.
Adsorbed bacteria were washed on a drop of H2O
for 5 min.
Negative staining
Negative staining was performed by floating the grids
on a drop of 0.25% phosphotungstic acid (PTA) with
0.01% bovine serum albumin in H2O for 30–40 s.
Excess liquid was blotted off with filter paper and
samples were air dried.
Immunolabelling
In order to prevent non-specific binding of primary
antibodies, samples were initially blocked for 20 min
with phosphate-buffered saline containing 0.2%
bovine serum albumin and 0.05% Tween 20 (PBS-
BT). As this step was shown to be unnecessary to
prevent background labelling, it was omitted in later
experiments. Antibodies used included mouse mono-
clonal anti-CFA/I and anti-CS3 as well as rabbit
polyclonal anti-CS3 and anti-CS6 antibodies. All the
antibodies were raised against purified antigens
(provided by Dr. F. Cassels, NIH, Bethesda, Mary-
land, USA). Rabbit sera were pre-adsorbed against a
panel of bacterial strains in order to remove irrelevant
antibodies. Monospecificity of all antibodies used
was confirmed on Western blots as described
(Burnette 1981).
For immunogold labelling, TEM grids were floated
on corresponding primary antibodies for 60 min
(diluted 1:100 or 1:50 in PBS-BT). The grids were
washed in PBS-BT for 5 min and incubated for another
60 min on a drop of either goat 15 nm gold-conjugated
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anti-mouse IgG diluted 1:100 in PBS-BT or goat
15 nm gold-conjugated anti-rabbit IgG (both from
British Biocell International, Brunschwig, Germany).
Double labelling was performed by incubation of
grids with a mixture of primary antibodies (mouse
monoclonal anti-CFA/I and rabbit polyclonal anti-
CS3 antibodies) followed by incubation with a
mixture of both appropriate secondary antibodies,
i.e., goat 10 nm gold-conjugated anti-mouse IgG
(Sigma, Missouri, USA) and goat 15 nm gold-conju-
gated anti-rabbit IgG (British Biocell International,
Brunschwig, Germany). Finally, the grids were
washed twice in H2O for 5 min. After blotting off
excess liquid with filter paper, negative staining and
air drying, grids were examined in a Zeiss 109
transmission electron microscope (Zeiss, Oberko-
chen, Germany) equipped with a GATAN wide angle
slow scan CCD Camera 689 (GATAN GmbH,
Munich, Germany).
Control experiments
Control experiments included negative staining and
immunolabelling of host strain CVD 103-HgR with anti-
CFA/I, anti-CS3 and anti-CS6 antibodies. Specificity of
labelling was assessed by simply omitting the primary
antibodies, as well as by using a rabbit anti-calcitonin
antibody (Anawa Biomedical Services and Products,
Zu¨rich, Switzerland) and a mouse anti-osteoprotegerin
antibody (R&D Systems, Oxon, UK) as irrelevant
substitutes for pertinent primary antibodies.
Results
Expression of CFA/I, CS3 and CS6 fimbriae
in wildtype strains
All antibodies used identified a single protein band of
the appropriate molecular weight in Western blot
Fig. 1 Expression of CFA/I antigen in wildtype strain H10407
(A, B), of CS3 antigen in wildtype strain DS7–3 (C, D) and of
CS6 antigen in wildtype strain E34420A (E, F) as revealed by
negative staining and immunogold labelling. Surface expres-
sion of CS6 fimbriae is combined with CFA/III fimbriae in
E34420A (E, F). CFA/III pili (arrowheads) are clearly visible,
whereas a narrow margin of phosphotungstic acid surrounding
the bacteria (arrows) is indicative of the presence of CS6 pili.
Scale bar = 0.5 lm
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analysis (data not shown). Analysis of plasmid
persistence revealed that plasmid loss was below
1% in the absence of antibiotic selection.
Expression of CFA/I was examined in the two CFA/
I-positive ETEC wildtype strains H10407 (Fig. 1A, B)
and CD79a (not shown). Negative staining clearly
revealed long, spiny and rod-like fimbriae (Fig. 1A).
The identity of these fimbriae as CFA/I was corrobo-
rated by immunogold labelling (Fig. 1B).
ETEC strains DS7–3 (Fig. 1C, D) and DS198–1
(not shown) were used as reference strains for the
CS3 surface antigen. In contrast to CFA/I, CS3
appeared to be thin and curly fibrils, as shown by
negative staining (Fig. 1C). Likewise, immunogold
labelling with both monoclonal and polyclonal anti-
bodies was highly specific and, thus, unequivocally
confirmed these hair-like structures to be CS3 surface
antigens (Fig. 1D). CFA/I and CS3 fimbriae expres-
sion requires the presence of one regulator gene.
CsfR and rns are fully interchangeable regulators and
one or the other was used at different periods in the
course of the experimental work leading to the
present publication.
As for CS6, negative staining only provided
evidence of a narrow margin of phosphotungstic
acid surrounding the bacteria. Consequently, only
one type of surface structure was detected in the
bivalent wildtype strains examined, i.e., long wavy
CFA/III fimbriae in E34420A (Fig. 1E) and rigid
but long CS5 fimbriae in E17018A (not shown).
However, immunogold labelling with polyclonal
CS6-specific antibodies yielded evidence of CS6
fimbriae surface expression in both strains,
although labelling density was much higher in
E34420A (Fig. 1F) than in E17018A (not shown).
Interestingly, labelling of CS6 structures was
superimposed over the cell body in both instances
(Fig. 1F) and, as opposed to CFA/I and CS3, no
halo of labelled fimbriae surrounding the cell body
was seen.
Fig. 2 Expression of CFA/I, CS3 and CS6 antigens in
monovalent recombinant strains as revealed by negative
staining (A, C, E) and immunogold labelling (B, D, F).
CFA/I (arrows) is displayed by BB01 (A, B), CS3 (arrowheads)
by CVD 103-HgR(pSSVI215-CS3/pM392) (C, D) and CS6 by
CVD 103-HgR(pM295) (E, F). Scale bar = 0.5 lm
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Expression of CFA/I, CS3 and CS6 in
recombinant monovalent V. cholerae strains
Negative staining of strain BB01, the recombinant
V. cholerae strain CVD 103-HgR harboring chro-
mosomally integrated genes for CFA/I, revealed
efficient expression of CFA/I fimbriae (Fig. 2A).
However, these surface structures were morpho-
logically different from their equivalents in
wildtype strains H10407 and CD79a (Fig. 1A).
Whereas CFA/I fimbriae in wildtype ETEC strains
were stiff, rod-like and short structures, fimbriae in
recombinant V. cholerae appeared to be longer,
less densely packed, undulated and less rigid.
However, immunogold labelling provided compel-
ling evidence that these surface structures are
immunogenically identical to CFA/I fimbriae
(Fig. 2B).
Fig. 3 Expression of CFA/I (arrowheads) and CS3 (arrows)
antigens in bivalent recombinant strains CHCS3-R2
(pSSVI215-cfaI) (A, B) and BB06 (C, D) as revealed by
negative staining (A, C) and immunogold labelling (B, D).
Binding sites for CFA/I are demonstrated with 10 nm colloidal
gold (B, D; arrowheads) and binding sites for CS3 are
demonstrated with 15 nm colloidal gold (B, D; arrows). Scale
bar = 0.5 lm
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In contrast to their presence in wildtype strains, CS3
fimbriae were difficult to visualize by means of
negative staining in the recombinant V. cholerae strain
CVD 103-HgR (pSSVI215-CS3/pM392) (Fig. 2C).
However, their presence as wispy structures was
demonstrated by immunolabelling (Fig. 2D). CS3
was expressed as bushy patches being disseminated
over the entire bacterial surface. This was in contrast to
CS3 expression in wildtype ETEC strains where the
fimbriae uniformely covered the whole cell surface.
Obviously, expression of corresponding genes pro-
duces fimbriae that are much frailer than in wildtype
ETEC strains. As judged from their scattered occur-
rence away from bacteria, they also seem to be more
easily lost during sample handling (not shown).
In accordance with the observations made on
wildtype strains, CS6 could not be demonstrated
morphologically on recombinant V. cholerae strain
CVD 103-HgR (pM295) either (Fig. 2E). Notwith-
standing, the specific labelling signal obtained with
polyclonal rabbit anti-CS6 antibodies (Fig. 2F) was
similar to the labelling density seen in wildtype strain
E17018A (not shown).
Expression of CFA/I and CS3 in recombinant
bivalent strains
On bivalent V. cholerae strain CHCS3-R2 (pSSVI215-
cfaI) (Fig. 3A), negative staining revealed CFA/I
fimbriae as long and curved tubes, whereas CS3
fimbriae could only be perceived as darker lumps on
the bacterial body. Double labelling (Fig. 3B) clearly
revealed the presence of both CS3 and CFA/I fimbriae.
As compared to CHCS3-R2 (pSSVI215-cfaI)
(Fig. 3A), presumptive CFA/I fimbriae on bivalent
strain BB06 were noted as partly adhering to the cell
surface and partly extending away from the bacteria
(Fig. 3C). Whereas CS3 fimbriae could only faintly be
sensed after negative staining, they were clearly
outlined as multifocal spots by immunolabelling
(Fig. 3D).
Negative controls
All host strains were devoid of background labelling
when incubated with anti-CFA/I, anti-CS6 or anti-
CS3 antibodies. Substitution of specific primary
antibodies with irrelevant counterparts abolished
any labelling in wildtype strains.
Discussion
There are different strategies to create vaccines
against bacterial infectious diseases, including puri-
fied antigens, inactivated whole cells, live attenuated
cells of the pathogen of interest or the use of live
bacterial carriers expressing the gene(s) coding for
the antigen(s) of interest. Advantages of the latter
approach are the availability of innocuous carrier
strains, the presentation of antigens that allow the
colonization process to be mimicked and the potential
of inducing excellent immune responses. An impor-
tant issue in this context is the need to express the
antigen in its immunogenic form. Structural modifi-
cations of the antigen as compared to the wildtype
strain may be associated with dissimilar epitope
conformations, thus leading to suboptimal immune
responses.
The goal of the present study was to investigate the
potential of expressing E. coli-specific surface anti-
gens in recombinant V. cholerae vaccine strains and to
compare their surface expression to ETEC wildtype
strains. Transmission electron microscopy, in combi-
nation with negative staining and immunogold
labelling, proved itself to be an essential tool for
assessment of the expression of E. coli-specific surface
antigens in the recombinant strain CVD 103-HgR.
Culture conditions and handling protocols first had
to be tailored carefully so as to ensure optimal gene
expression and preservation of the delicate fimbrial
structures. A number of factors, such as the compo-
sition of the culture media and washing solutions or
the incubation time and temperature, all affected their
presence. Centrifugation in particular turned out to be
detrimental to the preservation of small fimbrial-type
structures such as CS3 and CS6 (Novotny et al.
1969). Preliminary experiments thus led to the
protocols reported herein.
Furthermore, phase variation has been reported in
ETEC (Knutton et al. 1987; Sohanpal et al. 2001).
Although this phenomenon is mainly associated with
type 1 fimbriae, it should be considered as a possible
explanation for the observation that CS3 fimbriae
occasionally escaped morphological detection on
wildtype E. coli strain DS7–3.
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Morphological analysis of wildtype ETEC strains
and recombinant vaccine strains by means of nega-
tive staining provided impressive evidence of
substantial differences in the surface expression of
genetically and immunogenically identical CFs.
Thus, manifestation of both CFA/I and CS3 genes
results in morphologically clearly different structures
depending on whether expression takes place in
wildtype or recombinant strains. The reasons for this
variability have not been elucidated to date, but it
seems likely that genes other than the ones encoding
for the actual fimbriae are involved in the expression
process. V. cholerae naturally expresses Tcp fimbriae
(Ehara et al. 1987; Hall et al. 1988) and the expres-
sion and secretion machinery driving the synthesis of
Tcp fimbriae may affect the synthesis of some of the
ETEC CFs. This possibility is particularly compelling
in the case of CFA/I fimbriae in V. cholerae, which
bear a certain resemblance to Tcp fimbriae, while
being strikingly different from CFA/I fimbriae in
ETEC. In the case of CS3, expression in V. cholerae
results in a patchy pattern, whereas CS3 fimbriae
seem to be synthesized all over the surface of ETEC
wildtype strains. This is indicative of heterogeneity in
the surface composition of V. cholerae as to its
capacity to synthesize CS3 fimbriae. It will be
interesting to investigate whether such heterogeneity
correlates with some other functional properties of
V. cholerae. However, although the appearance of the
surface antigens may vary, their antigenicity is
obviously preserved. Thus, CFA/I, CS3, and CS6
pilins, the structural proteins making up the CFs,
were equally recognized by poly- and monoclonal
antibodies in Western blots of wildtype and recom-
binant strains and the corresponding polypeptides
were of the same size (Favre et al. 2006). In addition,
wildtype and recombinant strains (both monovalent
and bivalent) were specifically labelled by the same
antisera. Pertaining to the latter consideration, dou-
ble-labelling experiments provided evidence of co-
expression of CFA/I with CS3. This aspect is
essential in view of adopting a multivalent recombi-
nant approach towards a vaccine against ETEC.
Although visualizing CS6 fimbriae has not been
achieved to date (de Lorimier et al. 2003; Nishikawa
et al. 1998), we made numerous attempts to provide
morphological data on these surface structures in a
number of strains, including wildtype strains
E34420A, E17018A and B7A (data not shown), as
well as the recombinant strain CVD 103-HgR
(pM295) containing the genes encoding CS6 fimb-
riae. Whereas CS6 fimbriae eluded morphological
depiction, we were able to demonstrate their presence
by immunolabelling. Interestingly, colloidal gold tags
were strictly superimposed over the cell body, thus
providing suggestive evidence that CS6 fimbriae are
so short and thin that they do not protrude enough
from the bacterial surface to become apparent after
negative staining. This contention is further corrob-
orated by the observation that, in contrast to naked
bacteria, the contour of CS6-positive bacteria is
highlighted by a narrow margin of retained phospho-
tungstic acid.
Altering the adhesion behavior of the vaccine
strain CVD 103-HgR raises the question of possible
changes in its virulence. Virulence of V. cholerae is
specifically mediated by toxins. As the catalytic
subunit has been removed from CVD 103-HgR, this
host strain is devoid of virulence factors. Moreover,
ETEC fimbriae lack any intrinsic virulence and, thus,
it seems extremely unlikely that the expression of
ETEC fimbriae would restore some kind of virulence
in the host strain. This makes CVD 103-HgR a
suitable vector. Its innocuousness and its efficacy in
eliciting an immune response against ETEC-specific
antigens, however, will require adequate clinical
trials in vitro and in vivo.
Conclusions
Taken together, the results of the present study
clearly demonstrate that single or combined expres-
sion of genes encoding colonization factors in a
recombinant V. cholerae vaccine strain is feasible.
Although the morphology of the resulting CFs may
differ to some extent from their appearance in
wildtype strains, CFs are readily identified by specific
antibodies and, thus, obviously retain their antige-
nicity. Therefore, this approach holds a vast potential
for the generation of customized vaccines.
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